TrialEuropean radiology2018

The prognostic and predictive value of vascular response parameters measured by dynamic contrast-enhanced-CT, -MRI and -US in patients with metastatic renal cell carcinoma receiving sunitinib.

John M Hudson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.